Stereotaxis Inc. (STXS) announced Monday that it received regulatory approval of its Niobe remote magnetic technology for cardiac ablations in Japan.
Stereotaxis gapped up Monday and has risen above the morning's narrow range in the last few minutes on increased volume. The stock is now up 0.43 at $2.22. Stereotaxis has climbed to a 2-week high and has re-crossed both its 50 and 200-day moving averages.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.